T5	Subject 0 61	A 58-yr-old male patient with essential thrombocythaemia (ET)
T7	Effect 72 103	chronic myeloid leukaemia (CML)
T8	Treatment 110 168	continuous uneventful treatment with hydroxyurea for 18 yr
T9	Age 2 11	58-yr-old
T10	Gender 12 16	male
T11	Treat-Disorder 30 61	essential thrombocythaemia (ET)
T12	Drug 147 158	hydroxyurea
T13	Duration 163 168	18 yr
T6	Adverse_event 62 71	developed
E1	Adverse_event:T6 
